CAPITOL HILL CONSULTING GROUP

Lobbying for OCULAR THREPEUTIX · Biopharmaceutical company focused on therapies for the eye.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $20,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Medicare/Medicaid

Biopharmaceutical company focused on therapies for the eye. Issues related to Medicare reimbursement for therapies of the eye.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.